Patents by Inventor Bobak Robert Azamian

Bobak Robert Azamian has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240325078
    Abstract: According to various embodiments, systems, devices and methods for modulating targeted nerve fibers (e.g., hepatic neuromodulation) are provided. The systems may be configured to access tortuous anatomy of or adjacent hepatic vasculature. The systems may be configured to target nerves within a wall of (e.g., within adventitia surrounding a lumen of) an artery or other blood vessel, such as the common hepatic artery.
    Type: Application
    Filed: June 12, 2024
    Publication date: October 3, 2024
    Inventors: Bobak Robert Azamian, Jonathan Allen Coe, Scott Bradley Vafai
  • Publication number: 20240325079
    Abstract: According to various embodiments, systems, devices and methods for modulating targeted nerve fibers (e.g., hepatic neuromodulation) are provided. The systems may be configured to access tortuous anatomy of or adjacent hepatic vasculature. The systems may be configured to target nerves within a wall of (e.g., within adventitia surrounding a lumen of) an artery or other blood vessel, such as the common hepatic artery.
    Type: Application
    Filed: June 12, 2024
    Publication date: October 3, 2024
    Inventors: Bobak Robert Azamian, Jonathan Allen Coe, Scott Bradley Vafai
  • Publication number: 20240261017
    Abstract: According to various embodiments, systems, devices and methods for modulating targeted nerve fibers (e.g., hepatic neuromodulation) are provided. The systems may be configured to access tortuous anatomy of or adjacent hepatic vasculature. The systems may be configured to target nerves within a wall of (e.g., within adventitia surrounding a lumen of) an artery or other blood vessel, such as the common hepatic artery.
    Type: Application
    Filed: March 19, 2024
    Publication date: August 8, 2024
    Inventors: Bobak Robert Azamian, Jonathan Allen Coe, Scott Bradley Vafai
  • Publication number: 20240261016
    Abstract: According to various embodiments, systems, devices and methods for modulating targeted nerve fibers (e.g., hepatic neuromodulation) are provided. The systems may be configured to access tortuous anatomy of or adjacent hepatic vasculature. The systems may be configured to target nerves within a wall of (e.g., within adventitia surrounding a lumen of) an artery or other blood vessel, such as the common hepatic artery.
    Type: Application
    Filed: March 19, 2024
    Publication date: August 8, 2024
    Inventors: Bobak Robert Azamian, Jonathan Allen Coe, Scott Bradley Vafai
  • Patent number: 12029466
    Abstract: According to some embodiments, a method of treating a subject having diabetes or symptoms associated with diabetes is provided. The method includes delivering a neuromodulation catheter within a vessel (e.g., hepatic artery) having surrounding nerves that innervate the liver (e.g., sympathetic nerves of the hepatic plexus). The method may also include modulating (e.g., disrupting, ablating, stimulating) the nerves by mechanical compression, energy delivery, or fluid delivery.
    Type: Grant
    Filed: December 1, 2020
    Date of Patent: July 9, 2024
    Assignee: Medtronic Ireland Manufacturing Unlimited Company
    Inventors: Bobak Robert Azamian, Jonathan Allen Coe, Scott Bradley Vafai
  • Publication number: 20240206939
    Abstract: According to some embodiments, a method of treating a subject having diabetes or symptoms associated with diabetes is provided. The method includes delivering a neuromodulation catheter within a vessel (e.g., hepatic artery) having surrounding nerves that innervate the liver (e.g., sympathetic nerves of the hepatic plexus). The method may also include modulating (e.g., disrupting, ablating, stimulating) the nerves by mechanical compression, energy delivery, or fluid delivery.
    Type: Application
    Filed: March 5, 2024
    Publication date: June 27, 2024
    Inventors: Bobak Robert Azamian, Jonathan Allen Coe, Scott Bradley Vafai
  • Patent number: 12011212
    Abstract: According to various embodiments, systems, devices and methods for modulating targeted nerve fibers (e.g., hepatic neuromodulation) are provided. The systems may be configured to access tortuous anatomy of or adjacent hepatic vasculature. The systems may be configured to target nerves within a wall of (e.g., within adventitia surrounding a lumen of) an artery or other blood vessel, such as the common hepatic artery.
    Type: Grant
    Filed: December 6, 2019
    Date of Patent: June 18, 2024
    Assignee: Medtronic Ireland Manufacturing Unlimited Company
    Inventors: Bobak Robert Azamian, Jonathan Allen Coe, Scott Bradley Vafai
  • Publication number: 20240173062
    Abstract: According to some embodiments, a method of treating a subject having diabetes or symptoms associated with diabetes is provided. The method includes delivering a neuromodulation catheter within a vessel (e.g., hepatic artery) having surrounding nerves that innervate the liver (e.g., sympathetic nerves of the hepatic plexus). The method may also include modulating (e.g., disrupting, ablating, stimulating) the nerves by mechanical compression, energy delivery, or fluid delivery.
    Type: Application
    Filed: December 29, 2023
    Publication date: May 30, 2024
    Inventors: Bobak Robert Azamian, Jonathan Allen Coe, Scott Bradley Vafai
  • Publication number: 20240173061
    Abstract: According to some embodiments, a method of treating a subject having diabetes or symptoms associated with diabetes is provided. The method includes delivering a neuromodulation catheter within a vessel (e.g., hepatic artery) having surrounding nerves that innervate the liver (e.g., sympathetic nerves of the hepatic plexus). The method may also include modulating (e.g., disrupting, ablating, stimulating) the nerves by mechanical compression, energy delivery, or fluid delivery.
    Type: Application
    Filed: December 29, 2023
    Publication date: May 30, 2024
    Inventors: Bobak Robert Azamian, Jonathan Allen Coe, Scott Bradley Vafai
  • Publication number: 20240138896
    Abstract: According to some embodiments, a method of treating a subject having diabetes or symptoms associated with diabetes is provided. The method includes delivering a neuromodulation catheter within a vessel (e.g., hepatic artery) having surrounding nerves that innervate the liver (e.g., sympathetic nerves of the hepatic plexus). The method may also include modulating (e.g., disrupting, ablating, stimulating) the nerves by mechanical compression, energy delivery, or fluid delivery.
    Type: Application
    Filed: December 29, 2023
    Publication date: May 2, 2024
    Inventors: Bobak Robert Azamian, Jonathan Allen Coe, Scott Bradley Vafai
  • Publication number: 20240130773
    Abstract: According to some embodiments, a method of treating a subject having diabetes or symptoms associated with diabetes is provided. The method includes delivering a neuromodulation catheter within a vessel (e.g., hepatic artery) having surrounding nerves that innervate the liver (e.g., sympathetic nerves of the hepatic plexus). The method may also include modulating (e.g., disrupting, ablating, stimulating) the nerves by mechanical compression, energy delivery, or fluid delivery.
    Type: Application
    Filed: December 29, 2023
    Publication date: April 25, 2024
    Inventors: Bobak Robert Azamian, Jonathan Allen Coe, Scott Bradley Vafai
  • Publication number: 20240130774
    Abstract: According to some embodiments, a method of treating a subject having diabetes or symptoms associated with diabetes is provided. The method includes delivering a neuromodulation catheter within a vessel (e.g., hepatic artery) having surrounding nerves that innervate the liver (e.g., sympathetic nerves of the hepatic plexus). The method may also include modulating (e.g., disrupting, ablating, stimulating) the nerves by mechanical compression, energy delivery, or fluid delivery.
    Type: Application
    Filed: December 29, 2023
    Publication date: April 25, 2024
    Inventors: Bobak Robert Azamian, Jonathan Allen Coe, Scott Bradley Vafai
  • Publication number: 20240130772
    Abstract: According to some embodiments, a method of treating a subject having diabetes or symptoms associated with diabetes is provided. The method includes delivering a neuromodulation catheter within a vessel (e.g., hepatic artery) having surrounding nerves that innervate the liver (e.g., sympathetic nerves of the hepatic plexus). The method may also include modulating (e.g., disrupting, ablating, stimulating) the nerves by mechanical compression, energy delivery, or fluid delivery.
    Type: Application
    Filed: December 29, 2023
    Publication date: April 25, 2024
    Inventors: Bobak Robert Azamian, Jonathan Allen Coe, Scott Bradley Vafai
  • Publication number: 20230301971
    Abstract: Disclosed herein are methods for treating or preventing ophthalmic and dermatologic conditions in a patient, including ocular surface conditions such as blepharitis. The methods can include topically administering directly to an ocular surface of one or more eyes of a patient in need of treatment thereof an effective amount of an isoxazoline parasiticide, formamidine parasiticide, or other active ingredient, formulated into an ophthalmic composition, the ophthalmic composition further comprising a pharmaceutically acceptable vehicle. Compositions are also disclosed.
    Type: Application
    Filed: May 30, 2023
    Publication date: September 28, 2023
    Inventors: Bobak Robert Azamian, Douglas Michael Ackermann, Shawn D. Hickok, Joseph G. Vehige
  • Publication number: 20230293496
    Abstract: Disclosed herein are methods for treating or preventing ophthalmic and dermatologic conditions in a patient, including ocular surface conditions such as blepharitis. The methods can include topically administering directly to an ocular surface of one or more eyes of a patient in need of treatment thereof an effective amount of an isoxazoline parasiticide, formamidine parasiticide, or other active ingredient, formulated into an ophthalmic composition, the ophthalmic composition further comprising a pharmaceutically acceptable vehicle. Compositions are also disclosed.
    Type: Application
    Filed: May 30, 2023
    Publication date: September 21, 2023
    Inventors: Bobak Robert Azamian, Douglas Michael Ackermann, Shawn D. Hickok, Joseph G. Vehige
  • Patent number: 11752137
    Abstract: Disclosed herein are methods for treating or preventing ophthalmic and dermatologic conditions in a patient, including ocular surface conditions such as blepharitis. The methods can include topically administering directly to an ocular surface of one or more eyes of a patient in need of treatment thereof an effective amount of an isoxazoline parasiticide, formamidine parasiticide, or other active ingredient, formulated into an ophthalmic composition, the ophthalmic composition further comprising a pharmaceutically acceptable vehicle. Compositions are also disclosed.
    Type: Grant
    Filed: July 26, 2022
    Date of Patent: September 12, 2023
    Assignee: Tarsus Pharmaceuticals, Inc.
    Inventors: Bobak Robert Azamian, Douglas Michael Ackermann, Shawn D. Hickok, Joseph G. Vehige
  • Publication number: 20230218584
    Abstract: Disclosed herein are methods of treating or preventing vector-borne diseases including Lyme disease via delivery of one, two, or more systemic doses of an isoxazoline anti-parasitic therapeutic agent to an individual with confirmed or suspected infestation of Lyme disease.
    Type: Application
    Filed: March 15, 2023
    Publication date: July 13, 2023
    Inventors: Bobak Robert Azamian, Douglas Michael Ackermann, Christopher William Stivers, Shawn D. Hickok
  • Patent number: 11690826
    Abstract: Disclosed herein are methods for treating or preventing ophthalmic and dermatologic conditions in a patient, including ocular surface conditions such as blepharitis. The methods can include topically administering directly to an ocular surface of one or more eyes of a patient in need of treatment thereof an effective amount of an isoxazoline parasiticide, formamidine parasiticide, or other active ingredient, formulated into an ophthalmic composition, the ophthalmic composition further comprising a pharmaceutically acceptable vehicle. Compositions are also disclosed.
    Type: Grant
    Filed: July 26, 2022
    Date of Patent: July 4, 2023
    Assignee: Tarsus Pharmaceuticals, Inc.
    Inventors: Bobak Robert Azamian, Douglas Michael Ackermann, Shawn D. Hickok, Joseph G. Vehige
  • Patent number: 11690827
    Abstract: Disclosed herein are methods for treating or preventing ophthalmic and dermatologic conditions in a patient, including ocular surface conditions such as blepharitis. The methods can include topically administering directly to an ocular surface of one or more eyes of a patient in need of treatment thereof an effective amount of an isoxazoline parasiticide, formamidine parasiticide, or other active ingredient, formulated into an ophthalmic composition, the ophthalmic composition further comprising a pharmaceutically acceptable vehicle. Compositions are also disclosed.
    Type: Grant
    Filed: July 26, 2022
    Date of Patent: July 4, 2023
    Assignee: Tarsus Pharmaceuticals, Inc.
    Inventors: Bobak Robert Azamian, Douglas Michael Ackermann, Shawn D. Hickok, Joseph G. Vehige
  • Publication number: 20230190711
    Abstract: Disclosed herein are methods for treating or preventing ophthalmic and dermatologic conditions in a patient, including ocular surface conditions such as blepharitis. The methods can include topically administering directly to an ocular surface of one or more eyes of a patient in need of treatment thereof an effective amount of an isoxazoline parasiticide, formamidine parasiticide, or other active ingredient, formulated into an ophthalmic composition, the ophthalmic composition further comprising a pharmaceutically acceptable vehicle. Compositions are also disclosed.
    Type: Application
    Filed: February 15, 2023
    Publication date: June 22, 2023
    Inventors: Bobak Robert Azamian, Douglas Michael Ackermann, Shawn D. Hickok, Joseph G. Vehige